High-Sensitivity Cardiac Troponin T Determines All-Cause Mortality in Cancer Patients: A Single-Centre Cohort Study

Abstract

Based on our non-selected cohort of cardio-oncological patients, hs-cTnT was able to identify patients with high mortality by using a low cutoff of 7 ng/L. We conclude that measurement of hs-cTnT is an important tool to stratify the risk for mortality of cancer patients before starting chemotherapy.